Thereapeutic device for migraine treatment granted FDA clearance

Theranica, a prescribed digital therapeutics (PDT) company, has announced its Nerivio therapeutic device has received the Food and Drug Administration clearance to market for an expanded indication for acute treatment of episodic or chronic migraine.